Transfemoral aortic valve implantation with new-generation devices: the repositionable Lotus vs. the balloon-expandable Edwards Sapien 3 valve

医学 心脏病学 内科学 狭窄 倾向得分匹配 主动脉瓣 心脏骨骼 气球 外科 主动脉瓣置换术
作者
Luca Nai Fovino,Mostafa Rabea Abdelhaleem Badawy,Chiara Fraccaro,Augusto D’Onofrio,Paola Purita,Anna Chiara Frigo,Paola Tellaroli,Mauro Agnifili,Maurizio B. Tusa,Massimo Napodano,Gino Gerosa,Sabino Iliceto,Francesco Bedogni,Alaa El-Din R. Abdel-Rheim,Giuseppe Tarantini
出处
期刊:Journal of Cardiovascular Medicine [Lippincott Williams & Wilkins]
卷期号:19 (11): 655-663 被引量:25
标识
DOI:10.2459/jcm.0000000000000705
摘要

BACKGROUND: New-generation transcatheter heart valves have been developed to reduce complications of transcatheter aortic valve implantation (TAVI). With this study we sought to compare procedural and 30-day outcomes of the new-generation repositionable Boston Scientific Lotus (Lotus) and the balloon-expandable Edwards Sapien 3 (ES3) transcatheter heart valves. METHODS: A total of 315 patients with severe symptomatic aortic stenosis undergoing transfemoral TAVI with Lotus or ES3 included in two large Italian registries were considered for this analysis. After propensity matching, 93 matched pairs of patients were included. Outcomes were evaluated according to Valve Academic Research Consortium-2 definition at discharge and 30 days. RESULTS: There were no differences in baseline characteristics, except for lower mean aortic gradient and larger mean aortic annulus in the ES3-treated patients. Valve Academic Research Consortium-2 defined device success was high and comparable between groups (97.8 for Lotus vs. 98.9% for ES3, P = 0.09). The frequency of moderate/severe paravalvular leak was low and similar for both devices (2.2 vs. 1.1%, P = 0.10). At 30 days, both groups showed low all-cause mortality (5.4 vs. 1.1%, P = 0.10) and rates of disabling stroke (3.2 vs. 1.1%, P = 0.31). New pacemaker implantation was more common after Lotus deployment (31.7 vs. 10.5%, P < 0.001). CONCLUSION: Transfemoral TAVI with both Lotus and ES3 resulted in favorable clinical and hemodynamic procedural and 30-day outcomes. Rates of significant paravalvular leak were low with both devices. The Lotus valve was associated with higher risk of pacemaker implantation.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小蘑菇的应助被科研通管家采纳,获得10
刚刚
完美世界的应助被科研通管家采纳,获得10
刚刚
刚刚
Hello的应助被科研通管家采纳,获得10
刚刚
weiyi完成签到,获得积分20
刚刚
刚刚
1秒前
小学生库里完成签到,获得积分10
1秒前
DW的应助被科研通管家采纳,获得10
1秒前
标致的问芙完成签到 ,获得积分10
1秒前
null的应助被科研通管家采纳,获得10
1秒前
深情安青的应助被科研通管家采纳,获得10
1秒前
菠菜的应助被科研通管家采纳,获得10
1秒前
1秒前
2秒前
molihuakai的应助被Huangzhisong采纳,获得10
2秒前
fantasy的应助被Iris采纳,获得10
3秒前
hhb发布了新的文献求助10
3秒前
哈哈哈发布了新的文献求助10
4秒前
巧克力发布了新的文献求助30
4秒前
文静冰露完成签到,获得积分20
4秒前
送你一朵小红花完成签到,获得积分20
5秒前
5秒前
Andies发布了新的文献求助30
6秒前
YOUNG929的应助被夙夜采纳,获得10
7秒前
深情安青的应助被Judy采纳,获得10
7秒前
CipherSage的应助被小王小王采纳,获得10
8秒前
CipherSage的应助被李嘉盛采纳,获得10
8秒前
星燃发布了新的文献求助10
8秒前
汉堡包的应助被三分之二采纳,获得10
9秒前
yoshlpzxr发布了新的文献求助10
9秒前
秋风的应助被颜庸采纳,获得10
10秒前
上官若男的应助被侯玥嘟嘟嘟采纳,获得10
12秒前
饺子只吃边边完成签到,获得积分10
12秒前
13秒前
13秒前
NexusExplorer的应助被动听千山采纳,获得10
15秒前
molihuakai的应助被灝男采纳,获得30
16秒前
17秒前
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8177802
求助须知:如何正确求助?哪些是违规求助? 9568632
关于积分的说明 21799933
捐赠科研通 7772424
什么是DOI,文献DOI怎么找? 3432505
关于科研通互助平台的介绍 2556698
邀请新用户注册赠送积分活动 2478055